On this episode, Rich Thayer and Mickey Urdea are interviewing Nancy Gagliano, MD, MBA, to discuss her role as an executive leader of the National Institute of Health (NIH)’s RADx Tech, Rapid Acceleration of Diagnostics program. In this unique position, she helped oversee over one billion dollars of sponsored programs to bring millions of new COVID-19 tests to market, and in this exclusive interview, she helps outline exactly how the RADx program came to be, what lessons they learned, and what similar programs the NIH is planning to expand next.

Dr. Gagliano has more than 35 years of experience as a senior healthcare physician executive and practicing physician in internal medicine. Prior to her work for the National Institute of Health, Dr. Gagliano was the Chief Medical Officer of Culbert Healthcare Solutions, providing strategic guidance on healthcare consulting services. Before joining Culbert Healthcare, Dr. Gagliano spent six years with CVS Health holding senior leadership positions including as the Chief Medical Officer of Minute Clinic, and as a Senior Vice President overseeing key programs such as the enterprise smoking cessation program and the development of the company’s telemedicine program. Prior to her leadership roles at CVS Health, Dr. Gagliano was a practicing internal medicine physician and held numerous leadership positions at Massachusetts General Hospital and Massachusetts General Physicians Organization. She also currently serves on the board of directors for OraSure Technologies and is the Managing Director for Granite Healthcare Advisors. Dr. Gagliano holds an M.D. from Harvard Medical School, an MBA from Northeastern University, and a Bachelor’s of Science Degree from Union College in Computer Science and Biology.

Learn more about RADx here: https://www.nih.gov/research-training/medical-research-initiatives/radx